John Messina

Summary

Affiliation: Cephalon Inc
Country: USA

Publications

  1. doi Fentanyl buccal tablet
    John Messina
    Cephalon, Inc, Frazer, Pennsylvania 19355, USA
    Drugs Today (Barc) 44:41-54. 2008
  2. ncbi A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer
    Russell K Portenoy
    Beth Israel Medical Center, New York, NY 10003, USA
    Clin J Pain 22:805-11. 2006
  3. ncbi Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 0003, USA
    Curr Med Res Opin 23:223-33. 2007
  4. ncbi Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study
    David M Simpson
    Mount Sinai School of Medicine, New York, New York 10029, USA
    Clin Ther 29:588-601. 2007
  5. ncbi Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain
    Neal E Slatkin
    Department of Supportive Care, Pain and Palliative Medicine, City of Hope National Medical Center, Duarte, California 91010, USA
    J Support Oncol 5:327-34. 2007

Detail Information

Publications5

  1. doi Fentanyl buccal tablet
    John Messina
    Cephalon, Inc, Frazer, Pennsylvania 19355, USA
    Drugs Today (Barc) 44:41-54. 2008
    ..This monograph summarizes current data on the clinical pharmacology, efficacy, safety and tolerability of FBT relating to the management of opioid-tolerant patients with BTP in association with chronic pain...
  2. ncbi A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer
    Russell K Portenoy
    Beth Israel Medical Center, New York, NY 10003, USA
    Clin J Pain 22:805-11. 2006
    ..This double-blind, randomized, placebo-controlled study evaluated the efficacy, safety, and tolerability of FBT in opioid-treated patients with cancer-related BTP...
  3. ncbi Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 0003, USA
    Curr Med Res Opin 23:223-33. 2007
    ..FBT was evaluated for BTP in opioid-treated patients with chronic low back pain--the first such study in a population with chronic non-cancer pain...
  4. ncbi Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study
    David M Simpson
    Mount Sinai School of Medicine, New York, New York 10029, USA
    Clin Ther 29:588-601. 2007
    ..The fentanyl buccal tablet (FBT) provides a rapid onset of analgesia (10-15 minutes) by enhancing fentanyl absorption across the buccal mucosa...
  5. ncbi Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain
    Neal E Slatkin
    Department of Supportive Care, Pain and Palliative Medicine, City of Hope National Medical Center, Duarte, California 91010, USA
    J Support Oncol 5:327-34. 2007
    ..In conclusion, in this study of opioid-tolerant patients with chronic cancer pain and BTP, FBT was efficacious, well tolerated, demonstrated rapid onset of analgesia (within 10 minutes), and had a sustained effect...